[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
February 16, 2011

How Many “Me-Too” Drugs Is Too Many?

Author Affiliations

Author Affiliations: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

JAMA. 2011;305(7):711-712. doi:10.1001/jama.2011.152

On August 3, 2009, the US Food and Drug Administration (FDA) approved pitavastatin (Livalo), making it the eighth statin approved for use in the United States and seventh currently available for sale. This approval comes almost a quarter century after that for the first member of the class, lovastatin, 8 years after generic lovastatin was approved and 4 years after 2 additional statins, pravastatin and simvastatin, lost patent protection and generic versions of them entered the market.

First Page Preview View Large
First page PDF preview
First page PDF preview
×